4.7 Article

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling

Adrian Wullweber et al.

Summary: The study reveals that CIS is the stage of commitment for determining MIBC tumor subtype, which is crucial for patient prognosis and therapy response.

CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway

Guoqing Yang et al.

Summary: The study revealed that the high expression of ADAMTS9-AS1 in bladder cancer promotes cell proliferation, migration, and invasion while reducing apoptosis and autophagy. It was also observed that ADAMTS9-AS1 may regulate these processes through the PI3K/AKT/mTOR signaling pathway. Targeting ADAMTS9-AS1 could be a potential therapeutic approach for treating bladder cancer.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2021)

Article Oncology

TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway

Xi Yu et al.

Summary: This study revealed that downregulation of TSPAN7 in bladder cancer is associated with tumor progression and poor prognosis, and demonstrated the inhibitory effects of TSPAN7 on cancer cell proliferation and migration through multiple experiments. TSPAN7 inhibits bladder cancer cell growth by activating Bax, cleaved caspase-3, and PTEN pathways.

FRONTIERS IN ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT

Zhengnan Huang et al.

Summary: TEAD4 was found to be significantly upregulated in urinary bladder cancer tissues compared to normal tissues, and its upregulation was correlated with clinical stage, pathological grade, and poor clinical outcome. Functional studies demonstrated that TEAD4 knockdown suppressed cell migration and invasion by reducing the expression of epithelial-mesenchymal transition (EMT) related markers and transcription regulators. These results suggest that TEAD4 may serve as a novel prognostic biomarker and a promising therapeutic target for UBC.

ONCOTARGETS AND THERAPY (2021)

Article Oncology

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I-III Colorectal Cancer

Tong Yu et al.

Summary: The study highlights the crucial role of TEAD4 and its direct target gene SIX1 in driving colorectal cancer progression, with their aberrant expression predicting poor prognosis in stage I-III CRC patients.

CANCER MANAGEMENT AND RESEARCH (2021)

Article Cell Biology

ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway

Weipu Mao et al.

Summary: The study revealed that ID2 serves as a tumor suppressor in bladder cancer, with high ID2 expression associated with lower tumor staging and better survival rates. Mechanistically, ID2 inhibits the progression and metastasis of BCa through the PI3K/AKT signaling pathway.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo

Yali Zuo et al.

Summary: The study revealed that CERCAM is overexpressed in bladder cancer, promoting cell growth and invasion. In vivo experiments showed that CERCAM silencing suppressed tumor growth. The PI3K/AKT signaling pathway may play a role in the functions of CERCAM in bladder carcinoma.

CANCER MEDICINE (2021)

Article Oncology

C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways

Shi Li et al.

Summary: C19orf10 is significantly upregulated in BC tissues and human BC cell lines. High expression of C19orf10 correlates with malignant behaviors in BC. Through regulating the PI3K/AKT and Wnt/beta-catenin pathways, C19orf10 promotes malignancy and EMT in human bladder carcinoma cells.

JOURNAL OF CANCER (2021)

Review Oncology

Advances in bladder cancer biology and therapy

Linda Tran et al.

Summary: Recent developments in bladder cancer research have focused on identifying mutated genes, understanding cellular aspects, and advancing non-invasive diagnostic methods. Immune checkpoint inhibitor therapeutics have shown significant therapeutic impact, providing patients with better monitoring options and hope for prolonged survival.

NATURE REVIEWS CANCER (2021)

Article Cell Biology

An EMT-related gene signature for the prognosis of human bladder cancer

Rui Cao et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Biotechnology & Applied Microbiology

Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway

Shiyu Mao et al.

ONCOTARGETS AND THERAPY (2020)

Review Cell Biology

Guidelines and definitions for research on epithelial-mesenchymal transition

Jing Yang et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Medicine, General & Internal

Bladder Cancer: A Review

Andrew T. Lenis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Oncology

FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis

Ran Wei et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Immunology

Context-dependent EMT programs in cancer metastasis

Nicole M. Aiello et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Review Cell Biology

Regulation of TEAD Transcription Factors in Cancer Biology

Hyunbin D. Huh et al.

Article Oncology

Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells

Yanju Wu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Review Cell Biology

Mesenchymal-epithelial transition in development and reprogramming

Duanqing Pei et al.

NATURE CELL BIOLOGY (2019)

Article Cell Biology

TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression

Qun Zhang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Urology & Nephrology

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

J. Alfred Witjes et al.

EUROPEAN UROLOGY (2017)

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

Review Oncology

EMT, cell plasticity and metastasis

Christine L. Chaffer et al.

CANCER AND METASTASIS REVIEWS (2016)

Review Medicine, General & Internal

Bladder cancer

Ashish M. Kamat et al.

LANCET (2016)

Review Biochemistry & Molecular Biology

The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis

Yuhang Zhou et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Cell Biology

A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition

Wenting Xu et al.

CELL ADHESION & MIGRATION (2015)

Article Oncology

Emerging roles of TEAD transcription factors and its coactivators in cancers

Ajaybabu V. Pobbati et al.

CANCER BIOLOGY & THERAPY (2013)

Review Urology & Nephrology

Cadherin Switching and Bladder Cancer

Richard T. Bryan et al.

JOURNAL OF UROLOGY (2010)

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery et al.

Review Medicine, Research & Experimental

Biomarkers for epithelial-mesenchymal transitions

Michael Zeisberg et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)